Profile data is unavailable for this security.
About the company
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
- Revenue in TWD (TTM)1.66bn
- Net income in TWD-607.92m
- Incorporated1965
- Employees564.00
- LocationAdimmune CorpNo.3Section 1, Tanxing Road, Tanzi DistrictTAICHUNG 427TaiwanTWN
- Phone+886 425381220
- Fax+886 425382105
- Websitehttps://www.adimmune.com.tw/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Formosa Pharmaceuticals Inc | 133.70m | -298.43m | 6.43bn | -- | -- | 5.65 | -- | 48.10 | -2.22 | -2.22 | 0.9963 | 7.54 | 0.0803 | -- | 1.61 | -- | -17.91 | -40.34 | -19.62 | -44.21 | 86.96 | -- | -223.16 | -2,488.28 | -- | -- | 0.0277 | -- | 2,270.49 | -- | 20.75 | -- | -42.98 | -- |
| Panion & BF Biotech Inc | 2.01bn | 101.27m | 7.95bn | 321.00 | 78.52 | 4.29 | 29.15 | 3.96 | 1.18 | 1.18 | 23.42 | 21.62 | 0.6185 | 1.73 | 9.66 | -- | 3.12 | 4.08 | 4.82 | 5.63 | 52.66 | 52.37 | 5.04 | 5.93 | 0.8699 | 10.62 | 0.287 | 111.06 | -21.54 | 5.96 | -57.65 | -13.47 | 35.39 | -3.23 |
| Adimmune Corp | 1.66bn | -607.92m | 9.51bn | 564.00 | -- | 1.86 | -- | 5.74 | -1.44 | -1.44 | 3.93 | 11.92 | 0.1848 | 1.25 | 4.04 | -- | -8.27 | 0.6867 | -10.19 | 0.7739 | 27.82 | 30.11 | -44.75 | 3.04 | 1.99 | -24.75 | 0.3284 | 32.80 | -20.72 | 16.77 | -319.91 | -- | 38.05 | -- |
| Formosa Laboratories Inc | 4.69bn | 255.94m | 10.94bn | 480.00 | 43.10 | 1.46 | 18.23 | 2.33 | 2.11 | 2.11 | 38.90 | 62.49 | 0.3479 | 1.49 | 4.42 | -- | 0.7067 | 2.68 | 0.9689 | 3.61 | 44.30 | 35.40 | 2.03 | 8.75 | 1.18 | 0.8922 | 0.3155 | 27.38 | 15.80 | 10.16 | -69.16 | -6.52 | -11.60 | 32.22 |
| Standard Chem & Pharm Co Ltd | 6.71bn | 847.58m | 11.37bn | 1.13k | 13.42 | 1.92 | 7.10 | 1.69 | 4.74 | 4.74 | 37.50 | 33.05 | 0.6066 | 2.39 | 6.00 | -- | 10.98 | 9.68 | 20.02 | 17.61 | 43.81 | 43.75 | 18.10 | 17.02 | 1.93 | -- | 0.0795 | 60.34 | 6.64 | 11.80 | 2.39 | 17.40 | 29.97 | 12.47 |
| SCI Pharmtech Inc | 1.41bn | 484.24m | 11.47bn | 241.00 | 24.05 | 2.12 | 16.36 | 8.12 | 3.99 | 3.99 | 13.98 | 45.36 | 0.2211 | 1.82 | 4.61 | -- | 7.58 | 6.90 | 8.56 | 8.26 | 27.11 | 38.18 | 34.26 | 19.85 | 1.68 | 9.22 | 0.1692 | 42.38 | 33.83 | -9.10 | -4.55 | -8.00 | 44.67 | -16.35 |
Data as of Nov 14 2024. Currency figures normalised to Adimmune Corp's reporting currency: Taiwan Dollar TWD
5.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 13.07m | 3.04% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 3.62m | 0.84% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 2.18m | 0.51% |
| BlackRock Advisors (UK) Ltd.as of 03 Oct 2024 | 946.00k | 0.22% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 665.51k | 0.16% |
| Vanguard Fiduciary Trust Co.as of 31 Aug 2024 | 386.77k | 0.09% |
| TIAA-CREF Investment Management LLCas of 31 Aug 2024 | 266.00k | 0.06% |
| Vanguard Global Advisers LLCas of 30 Sep 2024 | 250.00k | 0.06% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 81.62k | 0.02% |
| State Street Global Advisors Ltd.as of 02 Oct 2024 | 73.00k | 0.02% |
More ▼
Data from 30 Jun 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
